Cleveland41m
Parkinson's Disease patients find hope in lobby of Playhouse Square
Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...
Bloomberg L.P.4h
GSK Steps Up Parkinson’s Focus With US Biotech Deal
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
Minot Daily News16h
Grant brings free virtual wellness to Parkinson’s Community
to individuals diagnosed with Parkinson’s Disease or Parkinsonism. YMCA360 offers a vast library of more than 6,000 on-demand videos, which participants can access from any internet-enabled device ...
BioPharma Dive18h
On Wall Street, ‘flat out’ failure of AbbVie schizophrenia drug leaves analysts stunned
Negative drug results cost AbbVie billions of dollars in market value and convinced analysts that Bristol Myers had placed a ...
BioPharma Dive22h
AbbVie’s $9B bet collapses as closely watched schizophrenia drug fails studies
Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...
How AbbVie can still benefit from Cerevel acquisition despite emraclidine setback
AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.